OPAM Workshop: Medical Review Officer Training Course: Toxicology Testing and the MRO, A Physician's Role in the Prevention and Treatment of Substance Abuse-285274

Video Transcription

Video Summary

The speaker discusses various aspects of validity testing for urine drug specimens, primarily focusing on terms and procedures related to detecting abnormal results such as invalid, dilute, and adulterated specimens. The importance of specificity in language is emphasized, particularly in distinguishing whether urine is 'consistent with normal human urine' rather than presuming it to be substandard without evidence. The discussion covers various tests, such as measuring creatinine levels and specific gravity, to ensure samples are genuine and have not been tampered with. The provided guidelines also address how labs and medical review officers (MROs) should handle situations where specimens are invalid, including situations demanding split specimen testing to reconfirm results. Moreover, the handling process for discrepancies in split specimen results and the significance of testing within allowed parameters are outlined, emphasizing clear and precise protocol adherence. The narrative also touches on the various outcomes of urine sample testing, including how and when to recollect samples under observation, alongside stressing the necessary communication and documentation practices to ensure the integrity and reliability of drug testing results.

Keywords

urine drug testing

validity testing

invalid specimens

dilute specimens

adulterated specimens

creatinine levels

specific gravity

split specimen testing

medical review officers